ClinicalTrials.gg
Sign In

Fatty Liver clinical trials

The registry lists 662 studies for Fatty Liver across more than 10 countries. 184 are recruiting or about to start. 251 of them are mainly about Fatty Liver (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10. Counting its narrower condition Non-alcoholic Fatty Liver Disease too: 2,015 studies, 453 open.

ClinicalTrials.gov finds 2,251 studies for Fatty Liver. How that becomes 661 here

This page counts the studies the registry files under Fatty Liver, and those it files under no condition that list Fatty Liverthemselves. Each study its search finds is placed by how the registry filed it and by the conditions it lists. ClinicalTrials.gov counts as of Nov 8, 2026. How condition pages count

  1. 2,251Found by its condition searchIt reads the conditions a study lists and their synonyms, and also titles and keywords.
  2. −1,352Filed under a narrower condition, counted on its own pageNon-alcoholic Fatty Liver Disease 1,337
  3. −50List Fatty Liver as a condition, but the registry did not file them under itMost often written as “MASH - Metabolic Dysfunction-Associated Steatohepatitis” (8), “Metabolic Associated Fatty Liver Disease” (7), and “Metabolic Dysfunction-associated Fatty Liver Disease” (7). The registry filed them under other conditions only, most often Diabetes Mellitus, Type 2 (15) and Obesity (13).
  4. −188Match it another way124 name it in the title, 8 in a keyword, and 56 by a synonym or other text the search reads.
  5. 661The count on this page65 of them list Fatty Liver in their own words; the registry filed them under no condition.

Get an email when these change. Save the Fatty Liver studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
327
Recruiting
117
Status unknown
64
Not yet recruiting
54
Terminated
33
Active, not recruiting
31

Phase

Phase 2
109
Phase 1
54
Phase 4
43
Phase 3
33
Early Phase 1
8

Where

United States
211
China
63
France
44
United Kingdom
44
Canada
41
Italy
33

Who runs them

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (13) · Assiut University (13) · Seoul National University Hospital (7) · Massachusetts General Hospital (6) · Tehran University of Medical Sciences (6) · University of Colorado, Denver (6) · Cairo University (6) · Tanta University (6)

What is being tested here

Drugs under test in Fatty Liver studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Semaglutide304
Pegozafermin224
Fructose203
Probiotic203
Efimosfermin alfa222
Tirzepatide212
Pioglitazone1210
Empagliflozin105
Obeticholic acid114
Tesamorelin102

Drug classes tested here GLP-1 receptor agonists 4 open · SGLT2 inhibitors 2 open · Statins 4

Coming up

11phase 3 studies under way
58studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest

Who these studies take

Of the 117 Fatty Liver studies recruiting now, 35 (30%) set no upper age limit and 63 (54%) stop at 75 or younger. 8 (7%) take children under 18. 2 (2%) are for women only and 1 (1%) for men only; 32 (27%) take healthy volunteers.

Recruiting studies that take each age, of 117
AgeWomenMen
106 (5%)5 (4%)
1898 (84%)97 (83%)
30109 (93%)108 (92%)
40110 (94%)109 (93%)
50109 (93%)108 (92%)
65100 (85%)99 (85%)
7573 (62%)72 (62%)
8544 (38%)42 (36%)

Across all 662 studies, recruiting or not: 54% stop at 75 or younger and 29% at 65; 12% take children; 4% are for women only and 4% for men only; 27% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Fatty Liver studies take

Of 41 phase 2 interventional studies under Fatty Liver, half reached primary completion within 24 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 133 mo8–47 · 21 studies——
Phase 224 mo16–36 · 41 studies——
Interventional, no phase21 mo10–39 · 145 studies—21 mo10–40 · 136 studies
Observational33 mo20–68 · 96 studies—35 mo21–68 · 87 studies

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 13, 2026.

Started recruiting2

Results posted1

Stopped1

Newly registered4

Studies

Recruiting first, then most recently updated. Showing 50 of 662. Browse all 662 → or search them.